Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

NCT05660083 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

HER2-negative Breast Cancer
Metastatic Breast Cancer
Metaplastic Breast Carcinoma
TNBC - Triple-Negative Breast Cancer

Interventions

DRUG: L-NMMA

Sponsor

The Methodist Hospital Research Institute

Collaborators

[object Object]